Clinical Trials Logo
  1. Home
  2. Coronary Heart Disease
  3. NCT06335901
  4. Details
NCT06335901 Clinical Trial

Clinical Characteristics and Outcomes of Coronary Heart Disease

Coronary Heart Disease Clinical Trial

— IMPROVE  

Official title:
Clinical Characteristics and Outcomes of Coronary Heart Disease: a Prospective Cohort Study

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT06335901
Other study ID # xx20190901
Secondary ID
Status Completed
Phase
First received
Last updated
Start date February 1, 2020
Est. completion date April 30, 2022

Study information
Verified date March 2024
Source Xinjiang Medical University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This study evaluated and compared the prognostic value of different Baseline data and clinical variables to develop a risk ractor ediction model in patients with CHD.

Recruitment information / eligibility
Status Completed
Enrollment 20000
Est. completion date April 30, 2022
Est. primary completion date January 31, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years to 79 Years
Eligibility Inclusion Criteria 1. Patients diagnosed with Coronary Heart Disease (CHD) admitted to The First Affiliated Hospital of Xinjiang Medical University. The diagnosis is based on clinical assessments, including symptomatic evaluation, electrocardiographic findings, and coronary imaging studies. Exclusion Criteria 1. Patients who have experienced a Myocardial Infarction (MI) within the last month. 2. Patients who have undergone coronary revascularization, such as coronary artery bypass grafting (CABG) or percutaneous coronary intervention (PCI), in the last three months. 3. Patients with a pre-planned coronary revascularization procedure.

Study Design

Related Conditions & MeSH terms

Intervention

Drug:
• Drug:Standard therapy
Percutaneous coronary Intervention

Locations
Country Name City State
China The First Affiliated Hospital of Xinjiang Medical University Ürümqi Xinjiang

Sponsors (1)
Lead Sponsor Collaborator
Xinjiang Medical University

Country where clinical trial is conducted

China, 

Outcome
Type Measure Description Time frame Safety issue
Primary Death (All-cause mortality?Cardiac mortality ) 5 years of follow-up deaths occurred during this period
Secondary Major adverse cardiovascular events 5 years of follow-up deaths occurred during this period
See also
  Status Clinical Trial Phase
Recruiting NCT05196659 - Collaborative Quality Improvement (C-QIP) Study N/A
Completed NCT05088291 - Application of a New X-ray Protective Device in Coronary Interventional Therapy
Completed NCT03076801 - Does Choral Singing Help imprOve Stress in Patients With Ischemic HeaRt Disease? N/A
Completed NCT04584645 - A Digital Flu Intervention for People With Cardiovascular Conditions N/A
Not yet recruiting NCT04995159 - Optimized Antiplatelet Therapy in Patients With CHD After Implantation of NeoVas™ BRS System N/A
Recruiting NCT02967718 - Innovation Research of Differentiation and Treatment Methods Based on CHD Phlegm and Blood Stasis Syndrome N/A
Completed NCT02888652 - Study on the Registration of Coronary Heart Disease Patients Undergoing PCI
Terminated NCT02045134 - Supplementation With Polyphenol-Rich Foods and Atrial Fibrillation After a Cardiac Surgery N/A
Completed NCT02163044 - The Hellenic Postprandial Lipemia Study (HPLS)
Active, not recruiting NCT02244853 - Heart Rate and Cardiovascular Diseases Prognosis in People With Stable Coronary Artery Disease N/A
Completed NCT02753829 - Home-based Cardiovascular Rehabilitation, Maintenance Phase, in Subjects With Coronary Artery Disease N/A
Completed NCT02440893 - Understanding the Effect of Metformin on Corus CAD (or ASGES)
Terminated NCT01906957 - Cognition and Exercise Training N/A
Completed NCT01920009 - Impact of Motivational Interviews Within Pharmacy Care Upon Adherence to Cardiovascular Medicines N/A
Completed NCT01826552 - Comparison of the Angiographic Result of the Orsiro Hybrid Stent With Resolute Integrity Stent Phase 4
Recruiting NCT01689688 - Healing Response to Everolimus-eluting Stent Implantation; Serial Assessment With opticaL Coherence Tomography N/A
Completed NCT01779401 - Clopidogrel Response Evaluation and AnTi-Platelet InterVEntion in High Thrombotic Risk PCI Patients N/A
Recruiting NCT01456364 - Intracoronary Stenting and Antithrombotic Regimen: ADjusting Antiplatelet Treatment in PatienTs Based on Platelet Function Testing Phase 4
Recruiting NCT01462799 - COR-PRIM: Problem-based Learning (PBL) After Coronary Heart Disease (CHD) - Long-term Evaluation in Primary Care of Self-care N/A
Completed NCT01486030 - Effect of Exercise Stress Testing on Peripheral Gene Expression Using Corus CAD (or ASGES) Diagnostic Test